Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial

Table 6

Outcomes of patients in the clopidogrel and ticagrelor groups.

	Clopidogrel (n = 223)	Ticagrelor (n = 214)	value
Major adverse cardiac events	17 (7.6%)	6 (2.8%)	0.031
Acute coronary syndrome, n (%)	14 (6.2%)	6 (2.8%)
Heart failure, n (%)	1 (0.4%)	0
Cerebrovascular events, n (%)	1 (0.4%)	0
Cardiac death, n (%)	1 (0.4%)	0
Noncardiac death, n (%)	3 (1.3%)	1 (0.4%)	0.371
Bleeding, n (%)	7 (3.2%)	8 (3.8%)	0.799